Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea C Pinnix

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Predictors of survival in contemporary practice after initial radiosurgery for brain metastasesAnna Likhacheva, Chelsea C Pinnix, Neil R Parikh, et al.
Leukemia & Lymphoma|May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 2026
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell LymphomaSavita V Dandapani, Sairah Ahmed, Timothy Robinson, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
Haematologica|November 11, 2021
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomaRaphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, et al.
JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Radiation Oncology (London, England)|September 27, 2015
Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphomaBassem Youssef, JoAnn Shank, Jay P Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology GroupAndrea K Ng, Joachim Yahalom, Jayant S Goda, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville ScoreSarah A Milgrom, Wenli Dong, Mani Akhtari, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Predictors of survival in contemporary practice after initial radiosurgery for brain metastasesAnna Likhacheva, Chelsea C Pinnix, Neil R Parikh, et al.
Leukemia & Lymphoma|May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
International Journal of Radiation Oncology, Biology, Physics|March 5, 2026
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell LymphomaSavita V Dandapani, Sairah Ahmed, Timothy Robinson, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
Haematologica|November 11, 2021
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomaRaphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, et al.
JAMA Oncology|July 11, 2024
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled TrialChelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Radiation Oncology (London, England)|September 27, 2015
Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphomaBassem Youssef, JoAnn Shank, Jay P Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology GroupAndrea K Ng, Joachim Yahalom, Jayant S Goda, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville ScoreSarah A Milgrom, Wenli Dong, Mani Akhtari, et al.
Pageof 16